SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-002522
Filing Date
2004-05-10
Accepted
2004-05-10 10:46:11
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. FORM 10-Q b50355tte10vq.htm 10-Q 266868
2 EX-10.42 AMENDED LICENSE AGREEMENT b50355ttexv10w42.txt EX-10.42 133920
3 EX-31.1 CERTIFICATION OF CEO b50355ttexv31w1.htm EX-31.1 7381
4 EX-31.2 CERTIFICATION OF CFO b50355ttexv31w2.htm EX-31.2 7392
5 EX-32.1 CERTIFICATION OF CEO PURSUANT TO SECT 906 b50355ttexv32w1.htm EX-32.1 2825
6 EX-32.2 CERTIFICATION OF CFO PURSUANT TO SECT 906 b50355ttexv32w2.htm EX-32.2 2884
  Complete submission text file 0000950135-04-002522.txt   423415
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 04791360
SIC: 2836 Biological Products, (No Diagnostic Substances)